Stock ULGX UROLOGIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Urologix, Inc. Share Price

Equities

ULGX

US9172731047

Advanced Medical Equipment & Technology

Delayed OTC Markets
Other stock markets
 14:48:12 08/03/2024 GMT 		5-day change 1st Jan Change
0.0001 USD +9,900.00% Intraday chart for Urologix, Inc. -.--% +9,900.00%
2016 A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. CI
2015 Urologix Conducting A Strategic Review CI

Financials

Sales 2013 16.48M 1.31B Sales 2014 14.01M 1.11B Capitalization 3.66M 291M
Net income 2013 -4M -318M Net income 2014 -7M -557M EV / Sales 2013 0.4 x
Net Debt 2013 3.04M 242M Net Debt 2014 4.62M 367M EV / Sales 2014 0.59 x
P/E ratio 2013
-0.8 x
P/E ratio 2014
-0.49 x
Employees 61
Yield 2013 *
-
Yield 2014
-
Free-Float 100%
More Fundamentals * Assessed data

Chart Urologix, Inc.

Dynamic Chart

Latest news about Urologix, Inc.

A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. CI
Urologix Conducting A Strategic Review CI
Transcript : Urologix, Inc., Q3 2015 Earnings Call, May 12, 2015
Urologix, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2015 CI
Urologix, Inc. Appoints Scott M. Madson as Chief Financial Officer Effective April 1, 2015 CI
Urologix, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2014 CI
Transcript : Urologix, Inc., Q2 2015 Earnings Call, Feb 05, 2015
Urologix, Inc. Announces Revenue Guidance for Second Quarter Ended on December 31, 2014 CI
Transcript : Urologix, Inc., Q1 2015 Earnings Call, Nov 04, 2014
Urologix, Inc. Reports Unaudited Earnings Results for the First Quarter Ended September 30, 2014; Provides Cash Flow Guidance for the Fiscal 2015 CI
Transcript : Urologix, Inc., Q4 2014 Earnings Call, Aug 19, 2014
Urologix, Inc. Announces Executive Changes CI
Urologix, Inc. Reports Unaudited Earnings Results for the Fourth Quarter and Year Ended June 30, 2014; Reports Impairment of Goodwill for the Second Quarter Ended June 30, 2014; Provides Earnings Guidance for the Full Year 2015 CI
Urologix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014 CI
Transcript : Urologix, Inc., Q3 2014 Earnings Call, May 06, 2014
More news

Highs and lows

Current year
0.00
Extreme 0
0.00
1 year
0.00
Extreme 0
0.00
3 years
0.00
Extreme 0
0.02
5 years
0.00
Extreme 0
0.02
10 years
0.00
Extreme 0
0.20
More quotes

Managers and Directors - Urologix, Inc.

Managers TitleAgeSince
Mitchell Dann FOU
 Founder 63 28/05/91
Scott Madson DFI
 Director of Finance/CFO 63 31/03/15
Lisa Ackermann SAM
 Sales & Marketing 51 15/06/11
Members of the board TitleAgeSince
Mitchell Dann FOU
 Founder 63 28/05/91
Sidney Emery BRD
 Director/Board Member 74 30/09/05
Christopher Barys BRD
 Director/Board Member 57 05/08/10
More insiders

Company Profile

21st North Inc. is not engaged in any operating activity. The Company has dissolved.
Sector
Advanced Medical Equipment & Technology
More about the company

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
UROLOGIX, INC. Stock Urologix, Inc.
+9,900.00% 2.13K
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.46% 218B
DANAHER CORPORATION Stock Danaher Corporation
+7.62% 184B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+13.29% 135B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.04% 62.38B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+11.92% 51.37B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.81% 50.9B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+1.17% 40.87B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+2.35% 36.28B
RESMED, INC. Stock ResMed, Inc.
+26.28% 31.88B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. ULGX Stock